ersonal use only

Prof. Rob Phillips

Chairman and CEO, Uscom Limited

May 2, 2022

Building the Future

Update

  • • Transformational Partnership

  • • New Products

  • • Expanded Markets

  • • Operational Agility

  • • Positioned for Growth

ASX: UCM

Uscom Update

ersonal use only

"While the world has been stunned by destabilised geopolitics, the pandemic and now war, Uscom continues to actively pursue global opportunity, international trade, operational expansion, and growth strategies while strengthening our position as a global advanced medical technology leader. During the last 6 months we have been forming transformational partnerships with global technology leaders, developing new products, appointing new distributors, establishing new regional operations, advancing clinical science, writing new IP, and advancing global trade; we are building the future of global medical technology."

Prof. Rob Phillips

(CEO of Uscom)

Medical Technology

ylno esu lanosre

GLOBAL VALUE

"Medical technology is the application of organized

knowledge and skills in the form of devices, medicines,

vaccines, procedures, and systems developed to solve a

health problem and improve quality of lives."

WHO

"Uscom is a world leading ASX listed, advanced medical technology company specialising in cardiovascular and pulmonary monitoring devices, with a global operational footprint and leadership in medical science and technology. Uscom has a global web of ~200 patents and IP applications, and over 600 publications validating the clinical benefits of its technologies."

Prof. Rob Phillips

Overview

ersonal use only

ASX Listed

Global cardiovascular and pulmonary medical technology

Visionary and innovative

corporate culture

Profit and Cash Flow

Profit & Cash Flow +ve China and Europe, 5 yrs operating cash and debt freeHigh Growth and Margins 9 year: total receipts up 535% and

24% CAGR.

Huge global addressable markets - 75% of all mortality

Margins 75%+

Global Vision and Ambitions

Sydney, Singapore, Beijing, Budapest, Auckland, London, Delawere. Actively focused on growth and scale

Patented Apex Technologies

World leading digital medical technologies, >200 IP submissions and a healthy R&D supported product pipeline

New Products

New global regulatory and distribution 3 new products for 2022

Product approvals for 2022 - up ~140%

Uscom Snapshot

Uscom is an established medical technology enterprise preparing for a growth inflection with a global footprint and an expanding international network of operations acting as hubs for new distributors

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Uscom Limited published this content on 02 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 May 2022 02:46:05 UTC.